Search clinical trials for: MLC1501

Total 14 results

CHIMES Society
Moleac Pte Ltd.

Recruiting

NeuroAiD Safe Treatment Registry (NeST)

Brain Injury | NeuroAiD Use

Indonesia, Malaysia
Moleac Pte Ltd.

Completed

Spinal Cord Injury - Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN)

Spinal Cord Injury

Malaysia
Moleac Pte Ltd.

Recruiting

MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits (MAESTOSO)

Stroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic

Singapore, Philippines
Moleac Pte Ltd.

Not yet recruiting

MLC1501 Study Assessing Efficacy in STROke Recovery (MAEStro)

Stroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
National University Hospital, Singapore

Completed

NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects (NEURITES)

Cognitive Impairment

Singapore, Philippines, Vietnam
National University Hospital, Singapore

Unknown

The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study (ATHENE)

Alzheimer Disease

Singapore
Shahid Beheshti University
Shahid Beheshti University of Medical Sciences

Completed

Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After Stroke

Stroke
University of the Philippines

Recruiting

MLC901 in Moderate Traumatic Brain Injury (ANDROMEDA)

Moderate Traumatic Brain Injury

Philippines
Ali Amini Harandi

Unknown

MLC901 for Moderate to Severe Traumatic Brain Injury (Specified Drug Code) (MLC901)

Traumatic Brain Injury

Iran, Islamic Republic of
Benobio Co., Ltd.

Not yet recruiting

Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

Age-Related Macular Degeneration

Australia
Moleac Pte Ltd.

Completed

NeuroAiD II™ (MLC901) in Mild Traumatic Brain Injury (SAMURAI)

Traumatic Brain Injury

Russian Federation
Shahid Beheshti University of Medical Sciences

Completed

Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine

Alzheimer Disease

Iran, Islamic Republic of
MycoMedica Life Sciences PBC

Recruiting

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 in Healthy Participants

Healthy Volunteers

Australia
Moleac Pte Ltd.
Moleac Australia Pty Ltd

Completed

Drug-Drug Interaction Study of MLC1501 Using Cocktail of Drugs Acting as Sensitive Clinical Probes/Substrates of Cytochrome P450 Isoenzymes and Transporters in Healthy Subjects

Stroke

Australia

Search clinical trials for: MLC1501

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations